CORCEPT THERAPEUTICS INC Increase (Decrease) in Other Operating Liabilities
CORCEPT THERAPEUTICS INC (CORT) reported Increase (Decrease) in Other Operating Liabilities of $327.00 thousand for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2012-11-08
- CORCEPT THERAPEUTICS INC increase (decrease) in other operating liabilities for the quarter ending 2012-09-30 was $183.00K, a 45.24% increase year-over-year.
- CORCEPT THERAPEUTICS INC increase (decrease) in other operating liabilities for the quarter ending 2012-06-30 was $210.00K, a 62.79% increase year-over-year.
- CORCEPT THERAPEUTICS INC increase (decrease) in other operating liabilities for the quarter ending 2012-03-31 was -$66.00K.
- CORCEPT THERAPEUTICS INC increase (decrease) in other operating liabilities for the quarter ending 2011-12-31 was -$121.00K, a 106.86% decline year-over-year.
- CORCEPT THERAPEUTICS INC increase (decrease) in other operating liabilities for fiscal 2011 was -$1.46M, a 181.22% decline from fiscal 2010.
- CORCEPT THERAPEUTICS INC increase (decrease) in other operating liabilities for fiscal 2010 was $1.79M.
- CORCEPT THERAPEUTICS INC increase (decrease) in other operating liabilities for fiscal 2009 was -$125.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month | Increase (Decrease) in Other Operating Liabilities 158 month | Increase (Decrease) in Other Operating Liabilities 161 month | Increase (Decrease) in Other Operating Liabilities 164 month | Increase (Decrease) in Other Operating Liabilities 167 month |
|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | $183.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $393.00K derived: sum of 2 quarters · filed 2012-11-08 | $327.00K 10-Q · filed 2012-11-08 | $206.00K derived: sum of 4 quarters · filed 2012-11-08 | ||||
| 2012-06-30 | $210.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $144.00K 10-Q · filed 2012-08-09 | $23.00K derived: sum of 3 quarters · filed 2012-08-09 | $149.00K derived: sum of 4 quarters · filed 2012-11-08 | ||||
| 2012-03-31 | -$66.00K 10-Q · filed 2012-05-10 | -$187.00K derived: sum of 2 quarters · filed 2012-05-10 | -$61.00K derived: sum of 3 quarters · filed 2012-11-08 | $68.00K derived: sum of 4 quarters · filed 2012-11-08 | $705.00K 10-Q · filed 2012-05-10 | |||
| 2011-12-31 | -$121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-13 | $5.00K derived: sum of 2 quarters · filed 2012-11-08 | $134.00K derived: sum of 3 quarters · filed 2012-11-08 | -$1.46M 10-K · filed 2012-03-13 | $771.00K 10-K · filed 2012-03-13 | |||
| 2011-09-30 | $126.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $255.00K derived: sum of 2 quarters · filed 2012-11-08 | -$1.34M 10-Q · filed 2012-11-08 | $427.00K derived: sum of 4 quarters · filed 2012-11-08 | $892.00K 10-Q · filed 2011-11-08 | |||
| 2011-06-30 | $129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$1.46M 10-Q · filed 2012-08-09 | $301.00K derived: sum of 3 quarters · filed 2012-08-09 | $203.00K derived: sum of 4 quarters · filed 2012-08-09 | $766.00K 10-Q · filed 2011-08-09 | |||
| 2011-03-31 | -$1.59M 10-Q · filed 2012-05-10 | $172.00K derived: sum of 2 quarters · filed 2012-05-10 | $74.00K derived: sum of 3 quarters · filed 2012-05-10 | |||||
| 2010-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-13 | $1.67M derived: sum of 2 quarters · filed 2012-03-13 | $1.79M 10-K · filed 2012-03-13 | |||||
| 2010-09-30 | -$98.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $31.00K 10-Q · filed 2011-11-08 | ||||||
| 2010-06-30 | $129.00K 10-Q · filed 2011-08-09 | |||||||
| 2009-12-31 | -$125.00K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |